Objectives: This thought analyzes the causal role of hepatitis C virus (HCV) in patients with lonesome myocarditis.

Objectives: This thought analyzes the causal role of hepatitis C virus (HCV) in patients with lonesome myocarditis, and its susceptibility to immunosuppression.

Background: Prevalence of HCV in unmarried myocarditis, its mechanism of damage, and possible treatment are still unknown.

Methods: Among 48 consecutive patients with myocarditis serologically covered for HCV and other cardiotropic viruses, 3 patients had anti-HCV antibodies. Clinical manifestation was heart failure in sum of two units cases, and left bundle-branch stiffen with moderate cardiac dysfunction was not away in patient 3. The three patients underwent two-dimensional echocardiography, coronary angiography, and endomyocardial biopsy. Nest polymerase chain reaction (PCR) for positive and negative strands of HCV onward sera and myocardial samples, and PCR for the in the greatest degree common cardiotropic viruses were performed. HCV in the myocardium was discovered by TORDJI-22 antibody.

Results: At histology, a lymphocytic myocarditis associated with myocytes positively stained through TORDJI-22 was shown in all. Cardiac autoantibodies were bring to lighted in all cases. Nested PCR showed the one and the other positive and negative strands of HCV RNA in serum and myocardium; other viral genomes were absent. Patients were treated with prednisone and azathioprine for 6 month with regaining of cardiac volumes and function. At 4-week ascendency biopsy, myocarditis progressed to a healed phase, granting HCV RNA was still detectable in the serum and myocardium. Cardiac improvement was maintained at the 12-month overall follow-up

Conclusions: HCV can be discovered in the myocardium of as many as 6% of patients with unmarried myocarditis; HCV myocarditis can benefit from immunosuppression despite persistence of viral genome, suggesting an immunomediated mechanism of damage.

clew words: hepatitis C virus infection; immune system; myocarditis

Abbreviations: ACE = angiotensin-converting enzyme; ANA = antinuclear antibodies; ANCA = antineutrophil cytoplasm antibodies; HCV = hepatitis C virus; LBBB = left bundle-branch block; LV = left ventricular; LVEF = left ventricular ejection fraction; PCR = polymerase chain reaction; RT = turn upside down transcriptase

**********

Treatment of myocarditis remains a major challenge possibly because of the multiplicity and the heterogeneity of its etiologic and pathogenetic mechanisms. In particular, the accrues of immunosuppressive treatment have been controversial (1-3); therefore, its efficacy is still speculative and considered contraindicated when a viral genome is demonstrated in the myocardiocytes. (4) Although enteroviruses are considered the greatest in number common pathogens responsible for viral myocarditis, (56) preliminary reports move that hepatitis C virus (HCV) infection may be associated with several myocardial diseases, including chronic myocarditis. (7-9) In this contemplation we report three cases of HCV-related myocarditis demonstrated through histologic and molecular biology techniques, which rejoined to immunosuppressive therapy despite evidence of persistent replication of viral genomes in cardiac myocytes.

MATERIALS AND METHODS

Patient Population

Serologic ordeals for HCV in addition to the mostly common cardiotropic viruses (echovirus, Coxsackievirus A and B cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, parvovirus B19 adenovirus, influenza virus A and B and parainfluenza virus) were performed in 48 consecutive patients (32 men and 16 women; mean [+ or -] SD age, 45 [+ or -] 149 years) with a clinical ,and histologic diagnosis of myocarditis, hospitalized from September 1998 to March 2000 in our institution. Three of these patients (two women and undivided man, 6.25%) had positive findings for serum anti-HCV antibodies. None had a history of chronic hepatitis or previous evidence of the infection. Patient 1 was a 35-year-old woman in whom, during the next to the first week after the delivery of her first child, progressive dyspnea and palpitation unfolded Her previous clinical history was dull and no infectious disease was recorded during the pregnancy. Patient 2 was a 18-year-old male child admitted to the hospital because of rigid cardiac failure (New York Heart Association class IV), with palpitation and progressive dyspnea appearing 1 year earlier in spite of treatment with digitalis, diuretic, and angiotensin-converting enzyme (ACE) inhibitors. He had received large doses of adriamycin, 750 mg/[msup2] material part surface, at the age of 10 years for a lymphoma with out and out remission; he also had received line transfusions. Patient 3 was a 62-year-old woman with ulcerative colitis, with a fresh history of recurrent episodes of chest pain lasting up to 20 min, occurring at stop and occasionally during effort, unresponsive to sublingual nitroglycerin administration, and angiographic evidence of normal coronary arteries. The patient was admitted to the hospital because of the persistence of chest pain and the appearance of a left bundle-branch block up (LBBB) associated with a moderate left ventricular (LV) dilatation and dysfunction.

...